IQGAP1 in microbial pathogenesis: Targeting the actin cytoskeleton  by Kim, Hugh et al.
FEBS Letters 585 (2011) 723–729journal homepage: www.FEBSLetters .orgReview
IQGAP1 in microbial pathogenesis: Targeting the actin cytoskeleton
Hugh Kim a, Colin D. White b, David B. Sacks c,⇑
aDepartment of Translational Medicine, Brigham and Women’s Hospital and Harvard Medical School, 1 Blackfan Circle, Boston, MA 02115, USA
bDepartment of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, 3 Blackfan Circle, Boston, MA 02115, USA
cDepartment of Laboratory Medicine, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA
a r t i c l e i n f o a b s t r a c tArticle history:
Received 28 November 2010
Revised 25 January 2011
Accepted 26 January 2011
Available online 2 February 2011
Edited by Renee Tsolis
Keywords:
EPEC
IQGAP1
Microbial pathogenesis
Salmonella0014-5793/$36.00 Published by Elsevier B.V. on beha
doi:10.1016/j.febslet.2011.01.041
⇑ Corresponding author. Fax: +1 301 402 1885.
E-mail address: sacksdb@mail.nih.gov (D.B. Sacks)Microbial pathogens cause widespread morbidity and mortality. Central to the pathogens’ virulence
is manipulation of the host cell’s cytoskeleton, which facilitates microbial invasion, multiplication,
and avoidance of the innate immune response. IQGAP1 is a ubiquitously expressed scaffold protein
that integrates diverse signaling cascades. Research has shown that IQGAP1 binds to and modulates
the activity of multiple proteins that participate in bacterial invasion. Here, we review data that sup-
port a role for IQGAP1 in infectious disease via its ability to regulate the actin cytoskeleton. In addi-
tion, we explore other mechanisms by which IQGAP1 may be exploited by microbial pathogens.
Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction a calponin homology domain, a WW domain, four IQ motifs (IQMicrobial pathogens are a major cause of morbidity and mortal-
ity worldwide. In the United States alone, an estimated 76 million
foodborne illnesses (caused primarily by Salmonella enterica
serovar typhimurium, Campylobacter jejuni, Shigella ﬂexneri,
Cryptosporidium parvum and Escherichia coli) occur annually, and
account for an estimated treatment cost of up to 83 billion US dol-
lars [1]. Despite considerable variation in themanner bywhich they
produce disease, most microbial pathogens exert and sustain their
effects by usurping a relatively limited number of signaling
pathways inside the host cell. In particular, microbes frequently
manipulate the cytoskeleton of the host cell, thereby facilitating
their attachment and entry [2–4]. Microbial pathogens also employ
several survival strategies, allowing them to migrate within the
host cell and avoid bactericidal defense mechanisms [2–4]. Control
of the host cell’s cytoskeleton is also integral to each of these stages
of infection, therefore proteins that govern cytoskeletal remodeling
participate inmicrobial pathogenesis. In this review, we summarize
recent evidence that strongly supports a role for the scaffold protein
IQGAP1 in infectious disease.
2. IQGAP1: a key modulator of cytoskeletal function
IQGAP1 is a ubiquitously expressed 189-kDa scaffold protein
that contains several protein-interacting domains. These includelf of the Federation of European Bi
.motifs bind calmodulin), and a region with signiﬁcant sequence
similarity to the catalytic domain of Ras GTPase-activating proteins
(GAPs) [5]. Each of these domains serves to mediate the interaction
of IQGAP1 with multiple distinct proteins [6]. By regulating the
function of its binding partners, IQGAP1 participates in diverse cel-
lular functions, ranging from small GTPase signaling to control of
cell proliferation and motility [6,7]. Of particular relevance in the
context of this article is the role of IQGAP1 in the maintenance of
cytoskeletal architecture. IQGAP1 binds actin directly [8], enhances
actin polymerization in vitro [9,10], and colocalizes with actin in
lamellipodia [11]. Moreover, IQGAP1 stimulates actin assembly
by forming complexes with N-WASP (neuronal Wiskott Aldrich
Syndrome protein) and Arp2/3 (actin-related protein 2/3) [12].
By controlling the activity of the small GTPases Rac1 and Cdc42,
IQGAP1 also modulates the cytoskeleton indirectly. (Note that, de-
spite its name, IQGAP1 is not a GAP and actually stabilizes Rac1
and Cdc42 in their active forms [11,13].) The role of IQGAP1 in cel-
lular signaling and cytoskeletal dynamics has been the focus of
several excellent reviews [5–7,14,15]. Here, we focus only on those
IQGAP1 functions germane to microbial pathogenesis.
3. IQGAP1 and microbial pathogenesis
Early evidence to implicate the involvement of IQGAP1 in
microbial pathogenesis was derived by gene proﬁling. Microarray
analysis revealed that <3.5% of 3500 genes in a human monocyte
cell line, U937, had altered expression following infection with
Mycobacteria. One of the genes identiﬁed was IQGAP1, which wasochemical Societies.
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duced IQGAP1 expression in murine splenic tissue after infection
by Yersinia pestis [17], suggesting that IQGAP1 may be a target
for pathogen-induced changes in the host cell. Consistent with this
postulate, IQGAP1 is known to interact with numerous proteins
that functionally link pathogenic microbes to host cell invasion
(Table 1). For example, IQGAP1 binding to Dia1, a Diaphanous-
related formin that assembles actin ﬁlaments, is required for phag-
ocytic cup formation [18], an essential step in microbial invasion
into host cells [19]. IQGAP1 also binds directly to selected bacterial
proteins with deﬁned roles in pathogen invasion, including the
E. coli-derived Tir and Ibe, and the S. typhimurium-derived SseI
[20–22] (Table 1). The functional consequences of these interac-
tions are discussed in more detail in the following paragraphs.
4. IQGAP1 is a target for S. typhimurium pathogenesis
4.1. Regulation of IQGAP1 for S. typhimurium invasion
As is characteristic of many cell-invasive pathogens, S. typhimu-
rium employs an elaborate molecular apparatus, called a type III
secretion system (T3SS), to facilitate its infection by injectingTable 1
Host- and pathogen-derived IQGAP1 binding partners relevant to microbial pathogenesis.
Proposed function(s) of interaction with IQGAP1
Host-derived IQGAP1 binding partner
Actin Cross-links actin ﬁlaments
Arf6 Links Arf6 to Rac1 activation and cell migration
Arp2/3 Links growth factor signaling to actin assembly
c-Src c-Src catalyzes tyrosine phosphorylation of IQGAP1 and
bridges IQGAP1 to VEGFR2
Calmodulin Regulates IQGAP1 function
CaMKII Unknown; may be involved in the regulation of cell
adhesion
CD44 Links hyaluronan to actin cytoskeleton
Cortactin Necessary for hyperoxia-induced tyrosine phosphorylation
of Src, and cortactin and ROS generation
ERK1/2 MAPK Scaffold
Exo70 Necessary for correct localization of the exocyst; regulates
protein synthesis, exocytosis and secretion
MEK1/2 MAPK Scaffold
N-WASP Activates N-WASP and stimulates actin assembly;
necessary for N-WASP localization at lamellipodia
PtdIns(4,5)P2 Maintains integrity of PIP2-containing lipid rafts
PLD2 Necessary for hyperoxia-induced tyrosine phosphorylation
of Src, and cortactin and ROS generation
Rac1/Cdc42 Inhibits intrinsic GTPase activity, thereby stabilizing active
form
ShcA Unknown; may be important in cytoskeletal
reorganization in response to activation of growth factor
receptors
WAVE2 Involved in lamellipodia formation in response to HGF
Pathogen-derived IQGAP1 binding partnera
Gag (M-MuLV) Necessary for virus trafﬁcking and replication
Ibe (EPEC) Appears to be necessary for Ibe function during infection
SseI (S. typhimurium) Necessary for SseI inhibition of cell migration in primary
macrophages and dendritic cells
Tir (EPEC) Regulates actin pedestal formation by EPEC
Abbreviations: Arf6, ADP-ribosylation factor 6; CaMKII, Ca2+/calmodulin-dependent prote
hepatocyte growth factor; Ibe, IQGAP1-binding effector protein; M-MuLV, moloney mu
PtdIns(4,5)P2, phosphatidylinositol 4,5-bisphosphate; PLD2, Phospholipase D2; ROS, reac
growth factor receptor-2; WAVE, WASP family Verprolin-homologous protein.
a The pathogen from which each protein is derived is indicated in parentheses.bacterial toxins directly into host cells [23]. Among the injected
effectors are SopE and SopE2, which act as guanine nucleotide ex-
change factors (GEFs). In their catalytically inactive forms, Rac1
and Cdc42 are bound to guanosine diphosphate (GDP). GEFs cata-
lyze the substitution of GDP by guanosine-50-triphosphate (GTP),
resulting in Rac1 and Cdc42 activation [24]. Once activated, Rac1
and Cdc42 activate N-WASP and the Arp2/3 complex, thereby pro-
moting actin polymerization and actin ﬁlament elongation at the S.
typhimurium-host cell interface [25]. These molecular events result
in the formation of membrane rufﬂes that facilitate S. typhimurium
internalization.
Recent published data indicate S. typhimurium modulates
IQGAP1 to gain entry into host cells [26]. IQGAP1 is recruited to
sites of S. typhimurium attachment to HeLa cells, and siRNA-
mediated knockdown of IQGAP1 reduces rufﬂe formation and de-
creases S. typhimurium infection by 33%. The magnitude of this ef-
fect may be limited by residual IQGAP1 in the siRNA-treated cells,
since S. typhimurium entry into IQGAP1-null mouse embryonic
ﬁbroblasts (MEFs) is reduced by 65% compared to control MEFs
[26]. These data suggest that IQGAP1 is usurped by S. typhimurium
to enter host cells. The molecular mechanisms underlying these
observations have begun to be characterized. Overexpression ofRelevance of binding partner to microbial pathogenesis Reference(s)
Intricately involved in many aspects of bacterial invasion [8,26,74]
Controls bacterial invasion by modulating host cell actin
remodeling
[75]
Promotes host cell membrane rufﬂing; essential for
S. typhimurium, S. ﬂexneri and Rickettsia conorii invasion
[12]
Promotes bacterial invasion [76]
EPEC-induced actin pedestals are formed
via a Ca2+/calmodulin-dependent pathway
[20,41]
Phosphorylates vimentin at Ser82, thereby positively regulating
EPEC invasion
[77]
Recruited to the bacterial attachment site during EPEC infection [78]
Tyrosine phosphorylation of cortactin is required for invasion of
biliary epithelium by C. parvum
[79]
Stimulated by S. typhimurium infection; involved in C. jejuni
internalization
[53,71]
Recruitment of the exocyst to localized areas of the host cell
membrane promotes S. typhimurium invasion
[80]
MAPK signaling targeted by cell-invasive bacteria; MEK activation
required for efﬁcient invasion of L. monocytogenes, S. typhimurium,
Chlamydophila pneumonia and Pseudomonas aeruginosa
[51,54,55]
Promotes host cell actin polymerization; essential for EPEC and
S. ﬂexneri invasion
[12,81]
PIP2 is metabolized at sites of S. typhimurium invasion [49]
PLD activity correlates with Acinetobacter baumannii pathogenesis [79]
Involved in host cell membrane rufﬂing; essential
for S. typhimurium invasion
[74,82,83]
Affects S. typhimurium adherence to host cell; involved
in C. pneumoniae invasion
[84]
Required for invasion of L. monocytogenes; regulates invasion
of S. typhimurium
[85]
Promotes viral replication [48]
Promotes EPEC invasion [21]
Disables host macrophage function [22]
Promotes EPEC invasion [20]
in kinase II; EPEC, enteropathogenic E. coli; ERK, extracellular-regulated kinase; HGF,
rine leukemia virus; MAPK, mitogen-activated protein kinase; MEK, MAPK kinase;
tive oxygen species; Tir, translocated intimin receptor; VEGFR2, vascular endothelial
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while reducing the amount of endogenous IQGAP1 markedly de-
creases the activity of both GTPases [13,26]. During S. typhimurium
infection of HeLa cells, the levels of active Rac1 and Cdc42 increase
>2-fold [26]. However, in IQGAP1-null MEFs, Rac1 and Cdc42 acti-
vation is abrogated and S. typhimurium invasion is decreased [26].
These ﬁndings imply that regulation of Rac1 and Cdc42 by IQGAP1
is important for S. typhimurium entry. Consistent with this hypoth-
esis, S. typhimurium infection is increased in cells transfected with
wild-type IQGAP1, but not in cells transfected with an IQGAP1
mutant that lacks Rac1 and Cdc42 binding [26]. Interestingly, an
IQGAP1 mutant that does not bind actin (termed IQGAP1G75Q
[27]) also fails to promote S. typhimurium entry [26]. Moreover,
in contrast to wild-type IQGAP1, IQGAP1G75Q does not translo-
cate to sites of S. typhimurium infection. Based on the data de-
scribed above, S. typhimurium invasion into host cells appears
contingent on IQGAP1 binding to both Rac1/Cdc42 and actin.
Based on research from our laboratory, we propose a model that
integrates the observations described above (Fig. 1). As previously
highlighted, S. typhimurium attachment to the host cell results in
the injection of effectors via the T3SS. Following their injection,
SopE and SopE2 catalyze the exchange of GDP on Rac1 and
Cdc42 for GTP. This facilitates actin polymerization. IQGAP1 bound
to actin translocates to the site of S. typhimurium attachment on
the host cell. Here, IQGAP1 binds to active Rac1 and Cdc42,A
C
Fig. 1. S. typhimurium targets IQGAP1 to invade host cells. (A) S. typhimurium binds to th
activation of Rac1 and Cdc42. (B) Active (GTP-bound) Rac1 and Cdc42 promote localized a
translocates to the site of S. typhimurium attachment. (C) IQGAP1 binds Rac1-GTP and Cdc
promote further local actin polymerization. (D) Ongoing actin assembly induces the
attachment site. This process promotes further actin polymerization, augmenting formati
within a S. typhimurium-containing vacuole (SCV).maintaining them in their GTP-bound form. IQGAP1 binding to
Rac1-GTP and Cdc42-GTP enhances actin polymerization, and re-
sults in the recruitment of additional IQGAP1 (which is also bound
to active Rac1 and Cdc42) to the site of S. typhimurium attachment.
The presence of increased Rac1-GTP and Cdc42-GTP bound to
IQGAP1 further augments actin polymerization, inducing the
formation of membrane rufﬂes and facilitating S. typhimurium
internalization. IQGAP1 therefore functionally links Rac1 and
Cdc42 to actin, augments actin polymerization, and promotes
bacterial invasion.
4.2. S. typhimurium targets IQGAP1 to establish chronic infection
An important aspect of S. typhimurium pathogenicity is the abil-
ity of certain species to establish chronic, long-term infection in
the host by evading the host’s immune response [28,29]. The
capacity of S. typhimurium to survive and replicate in macrophages
is therefore of major importance to the ability of the pathogen to
cause disease. Macrophages are key participants in cell-mediated
immunity as they destroy foreign pathogens and function as anti-
gen-presenting cells [30]. The S. typhimurium pathogenicity island
2 (SPI2)-coded T3SS injects proteins that enable S. typhimurium to
create a S. typhimurium-containing vacuole (SCV) in which it can
replicate [31]. Moreover, SPI2-secreted effectors allow intracellular
bacteria to avoid the bactericidal properties of macrophages andB
D
e host cell membrane and injects effector proteins (small circles) that catalyze the
ctin polymerization at the S. typhimurium-host cell interface. IQGAP1 bound to actin
42-GTP, stabilizing the GTPases in their active GTP-bound forms. The active GTPases
accumulation of additional IQGAP1, with attached active Rac1 and Cdc42, at the
on of membrane rufﬂes that engulf the S. typhimurium. S. typhimurium is internalized
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[32]. One such Salmonella effector, SseI (also known as SrfH), im-
pedes the normal migration of macrophages and dendritic cells,
thus severely impairing their bactericidal abilities [22]. Conse-
quently, mice infected with wild-type S. typhimurium continue to
exhibit increased systemic levels of bacteria up to 45 days post-
infection, while mice infected with SseI-deﬁcient S. typhimurium
clear the pathogen more rapidly [22]. Importantly, IQGAP1 may
contribute to the ability of S. typhimurium to circumvent the host’s
immune response and establish chronic infection. IQGAP1 binds
SseI directly in vitro, and colocalizes with SseI in S. typhimurium-
infected macrophages [22]. Moreover, the inhibitory effect of SseI
on macrophage migration is contingent on IQGAP1 expression;
SseI does not impair migration of macrophages lacking IQGAP1
[22]. The S. typhimurium effector SseI therefore exploits IQGAP1
to reduce macrophage motility, thereby suppressing host immu-
nity and promoting a chronic infective state.
5. IQGAP1 is a target for E. coli pathogenesis
Like S. typhimurium, enteropathogenic E. coli (EPEC) utilizes a
T3SS to establish infection in the host [23]. Evidence suggests that
this is a multi-step process [33]. First, EPEC injects translocated
intimin receptor (Tir) into the host cell. Tir is inserted into the host
cell plasma membrane, where it binds intimin, which is embedded
in the bacterial outer membrane [34]. Tir-intimin adhesion leads to
Tir clustering, which recruits the host protein Nck. Binding to inti-
min also catalyzes phosphorylation of Tir by the host cell non-
receptor tyrosine kinase c-Fyn, resulting in N-WASP and Arp2/3
recruitment to the cell-microbe interface [35,36]. N-WASP medi-
ates actin polymerization, thereby creating an ‘‘actin pedestal’’.
This structure, which is an essential hallmark of E. coli pathogene-
sis [33], elevates and supports the EPEC above the surface of the
epithelial cell.
EPEC manipulates IQGAP1 to mediate infection. Speciﬁcally,
EPEC induces the translocation of IQGAP1 to actin pedestals where
IQGAP1 is necessary for pedestal formation [20]. Moreover, actin
polymerization induced by EPEC in IQGAP1-null MEFs is signiﬁ-
cantly less than that in control cells, and reconstitution of IQGAP1
into IQGAP1-null MEFs rescues EPEC infection. Interestingly, the
molecular mechanisms underlying these observations are different
to those of S. typhimurium. In contrast to S. typhimurium, which
promotes the binding of IQGAP1 to Rac1 and Cdc42 [26], EPEC
inhibits the interaction of IQGAP1 with the Rho GTPases [20]. An-
other important difference between S. typhimurium and EPEC is
that the latter modulates association of IQGAP1 with calmodulin
[20]. Calmodulin, a 16.7-kDa Ca2+-binding protein, is an important
transducer of Ca2+ signals [37]. Ca2+ signaling is necessary for actin
remodeling near the cell surface [38], and increases in intracellular
free Ca2+ concentrations ([Ca2+]i) are required for EPEC-induced ac-
tin pedestal formation [39,40]. Importantly, treatment with a cell-
permeable calmodulin antagonist (CGS9343B) or a cell-permeable
Ca2+ chelator (1,2-bis(2-aminophenoxy)ethane-N,N,N0,N0-tetraace-
tic acid tetrakis(acetoxymethyl ester) (BAPTA/AM)) abrogates actin
pedestal formation in wild-type but not IQGAP1-null MEFs [20].
These data indicate that Ca2+/calmodulin signaling by EPEC to
induce actin pedestal formation is mediated entirely through
IQGAP1. Thus, although both S. typhimurium and E. coli usurp
IQGAP1 function, the bacteria employ different molecular mecha-
nisms and exploit distinct IQGAP1 binding partners to infect host
cells.
Additional insight into how EPEC manipulates IQGAP1 is de-
rived from research from both our laboratory and other investiga-
tors. IQGAP1 interacts directly with EPEC-derived effector proteins
that are injected into the host cell and facilitate infection [20,21].For example, IQGAP1 binds Tir in vitro, and confocal microscopy
reveals that IQGAP1 colocalizes with Tir at EPEC-induced actin
pedestals [20]. Subsequently, another bacterial protein, termed
IQGAP1-binding effector protein (Ibe), was shown to regulate Tir
phosphorylation and actin pedestal formation [21]. Like Tir,
IQGAP1 binds Ibe in vitro, and colocalizes with Ibe at actin pedes-
tals. Although the mechanism underlying the contribution of Ibe to
EPEC pathogenesis remains to be deﬁned, these data provide fur-
ther evidence that IQGAP1 is a critical component of E. coli
infection.
Research carried out in our laboratory integrates the ﬁndings
discussed above (Fig. 2). In this model, EPEC binds to the surface
of cells and injects effectors via its T3SS. One of the effectors in-
jected, Tir, associates with intimin and is retained at the site of
infection. IQGAP1, presumably via its interaction with Tir, also
accumulates at the EPEC injection site. Simultaneously, EPEC in-
duces an increase in [Ca2+]i, thereby enhancing the association of
IQGAP1 with calmodulin, which reduces IQGAP1 binding to Rac1
and Cdc42 [41]. Because it is bound to IQGAP1, calmodulin accu-
mulates at the site of bacterial adhesion. Recruitment of Nck in-
duces clustering of N-WASP and Arp2/3 at the cell-microbe
interface, thereby promoting polymerization of actin. The presence
of IQGAP1 and calmodulin, and the interaction of IQGAP1 with Tir,
augments this localized actin polymerization, contributing to ped-
estal formation. Additionally, IQGAP1 bundles actin to ensure that
an ordered structure of parallel ﬁlaments is formed.
6. Other bacteria regulate IQGAP1
In addition to being manipulated by S. typhimurium and EPEC,
IQGAP1 is exploited by other pathogens as part of their infective
mechanisms. For example, a fundamental aspect of Shigella patho-
genesis is the intercellular spread of bacteria within epithelial tis-
sues [42]. Initial data indicate that intercellular spread of S. ﬂexneri
is signiﬁcantly enhanced in IQGAP1-null MEFs, suggesting that
IQGAP1 may be targeted during S. ﬂexneri infection (R. Lu, D.B.
Sacks, M.B. Goldberg, unpublished observations). Other ﬁndings
concern the regulation of IQGAP1 during infection of host cells
by Pseudomonas aeruginosa and Helicobacter pylori. In HL60 leuke-
mia cells, IQGAP1 is recruited to sites of P. aeruginosa attachment
[43]. Moreover, infection of human antral epithelial cells with H.
pylori increases IQGAP1 mRNA and induces translocation of
IQGAP1 protein from the cytoplasm to intracellular tubulovesicular
structures [44]. Collectively, these ﬁndings implicate IQGAP1 as a
host cell target for infection by several bacteria. Further work is
likely to identify additional bacteria that manipulate IQGAP1 to
facilitate host cell infection.
7. IQGAP1 as a target for viral pathogenesis
Viruses are strictly dependent on host cells for the transcription
of their genomes [45]. Invasionof host cells is therefore an important
determinant of viral pathogenesis. Gag proteins are major virulence
factors produced by retroviruses since they promote viral binding to
the host cell membrane [46]. Thematrix protein domains of Gag are
particularly important for the intracellular trafﬁcking of viral pro-
teins [47]. Evidence suggests that IQGAP1may also be a target of vir-
al pathogenesis. The Gag matrix protein of the Moloney murine
leukemia virus (M-MuLV) binds IQGAP1, and this binding is essen-
tial for viral replication [48]. Moreover, viruses encoding mutant,
non-IQGAP1-binding matrix proteins are replication deﬁcient, and
M-MuLV replication is reduced when IQGAP1 is knocked down in
host cells with siRNA. Additional studies are needed to determine
whether other viruses also require IQGAP1 for replication, and/or
whether IQGAP1 participates in viral infection in other ways.
A B
C D
Fig. 2. IQGAP1 and Ca2+/calmodulin are required for actin pedestal formation by EPEC. (A) EPEC binds to the surface of the host cell and injects effector proteins, including Tir,
thereby promoting a transient increase in [Ca2+]i. (B) IQGAP1 binds Tir directly and is recruited to the site of EPEC adhesion. The increase in [Ca2+]i promotes the interaction of
IQGAP1 with calmodulin (CaM), with a concomitant disruption of its association with Rac1 and Cdc42. (C) Following its binding to intimin, Tir is clustered and tyrosine-
phosphorylated, inducing the recruitment of Nck to the site of EPEC attachment. Nck directs N-WASP and the Arp2/3 complex to clustered Tir, where together they form an
IQGAP1-containing complex that promotes actin polymerization. (D) IQGAP1 contributes to ongoing actin polymerization, resulting in the formation of a pedestal structure
that supports EPEC. Additionally, IQGAP1 bundles actin to ensure that an ordered structure of parallel ﬁlaments is formed.
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We have reviewed evidence which reveals that IQGAP1 inter-
acts with numerous proteins known to be directly involved in host
cell infection and/or microbial survival. In addition, other IQGAP1-
interacting partners, such as phosphoinositides [49], microtubules
[50] and mitogen-activated protein kinases (MAPKs) [51–53], are
targeted by microbial pathogens [54–57] (Table 1). Conceivably,
these IQGAP1 binding molecules may also be modulated during
microbial pathogenesis in an IQGAP1-regulated manner. Although
no experimental evidence has been published to date, we suggest
possible contributions of these IQGAP1 binding partners to infec-
tious disease.
8.1. IQGAP1, phosphoinositides and microbial pathogenesis
Phosphoinositides are cell membrane-based signaling mole-
cules that are critical for cytoskeletal remodeling and intracellular
trafﬁcking processes [58]. The seven known phosphoinositides are
derived from phosphorylation of the precursor molecule, phospha-
tidylinositol (PI). PI is phosphorylated on the inositol ring by PI
kinases to produce several distinct phosphoinositides. These sig-
naling molecules have multiple functions, including regulation of
cytoskeletal rearrangement, which is required for invasion by mi-
crobes. For example, E. coli invades human brain endothelial cells
in a PI3-kinase-dependent manner [59]. Similarly, PI3-kinase is
targeted by Listeria monocytogenes during invasion of Vero cells[60] and by S. typhimurium during entry into ﬁbroblasts [55]. Like
IQGAP1, the phosphoinositide PI(4,5)P2 (PtdIns(4,5)P2) promotes
actin assembly by activating N-WASP and the Arp2/3 complex
[61], and PtdIns(4,5)P2 is enriched in areas undergoing active actin
polymerization (such as the S. typhimurium-host cell interface)
[62]. Importantly, a functional interaction between IQGAP1 and
PtdIns(4,5)P2 has been established. IQGAP1 colocalizes with
PtdIns(4,5)P2 at the leading edge of growth factor-stimulated cells,
and knockdown of IQGAP1 results in fragmentation of
PtdIns(4,5)P2-enriched lipid rafts [49]. Based on these data, it is
tempting to speculate that PtdIns(4,5)P2 activity at the cell mem-
brane may be regulated by IQGAP1, and that this interaction may
play a role in microbial invasion of the host cell.
8.2. IQGAP1 and microtubules in bacterial invasion
Microtubules are elements of the cytoskeleton and are essential
for cell division, cell migration, vesicle transport and cell polarity
[63]. Some pathogenic bacteria, including S. typhimurium, E. coli,
Shigella, L. monocytogenes and C. jejuni, exploit host microtubule
networks [55,64–67]. For example, pretreatment of ﬁbroblasts
with microtubule-depolymerizing agents such as colchicine or
nocodazole impairs S. typhimurium invasion, suggesting that intact
microtubule networks are required for entry of the bacteria [55]. In
this context, IQGAP1 regulates microtubule function through its
interaction with CLIP-170 and mDia1 [50,68]. Moreover, siRNA-
mediated knockdown of IQGAP1 results in decreased stability
and increased dynamics of microtubules [68]. Additional work is
728 H. Kim et al. / FEBS Letters 585 (2011) 723–729necessary to establish whether microbial pathogens target the
microtubule-stabilizing functions of IQGAP1 during host cell entry.
8.3. IQGAP1 and MAPKs in bacterial invasion
MAPKs transmit extracellular signals to a diverse array of nucle-
ar and cytoplasmic targets [69,70]. Stimulation of cell surface
receptors, such as the epidermal growth factor receptor, activates
the small GTPase Ras. Ras stimulates B-Raf kinase activity, which
catalyzes the sequential phosphorylation of MEKs (or MAPK ki-
nases) and extracellular-regulated kinases (ERKs). In addition to
being a pivotal determinant of eukaryotic gene expression, cell dif-
ferentiation and cell migration [70], the MEK/ERK pathway is also
involved in microbial pathogenesis. For example, MEK and ERK
activity are increased in cells infected with S. typhimurium [71].
Moreover, pretreatment of cells with the MEK inhibitor PD98059
curtails invasion into some cell types by several organisms,
including L. monocytogenes [54], S. typhimurium [55], Chlamydia
pneumoniae [72] and P. aeruginosa [73]. Importantly, IQGAP1 is a
scaffold in the MAPK pathway. IQGAP1 binds to and regulates
the function of multiple components of the MAPK cascade
[51–53]. For example, knockdown of IQGAP1 by siRNA abrogates
the activation of MEK [51] and ERK [53] by epidermal growth fac-
tor. Moreover, stimulation of B-Raf requires IQGAP1 as B-Raf ki-
nase activity is not induced by growth factors in IQGAP1-null
MEFs [52]. These data reveal that IQGAP1 is necessary for activa-
tion of MAPK signaling. Based on the evidence outlined above, it
is likely that IQGAP1 is important for MAPK-driven microbial
invasion.
9. Perspectives
Recent evidence strongly supports the concept that selected
microbial pathogens regulate the host cell’s cytoskeleton, at least
in part by usurping IQGAP1 function. These observations raise sev-
eral intriguing questions. For example, are the IQGAP1-dependent
molecular mechanisms underlying the entry of other cell-invasive
pathogens, such as S. ﬂexneri and P. aeruginosa, analogous to those
of S. typhimurium?What is the contribution of other molecules that
bind IQGAP1, such as Ibe, phosphoinositides, microtubules and
MAPKs, to the cytoskeletal rearrangements elicited by bacterial
infection? The current literature indicates that IQGAP1 may be
modulated at different stages during the infectious disease process.
It is likely that comparing infection of wild-type and Iqgap1/
mice will therefore yield insight into the development and clinical
progression of microbial pathogenesis. We look forward to the
ﬁndings from these and other investigations, which will enhance
our comprehension of pathogen biology and evaluate the feasibil-
ity of targeting IQGAP1 for the prevention and treatment of infec-
tious disease.
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